Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism
Molecular Metabolism · 2025
DOI: 10.1016/j.molmet.2025.102136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Metabolism, 2025. Verfasst von Callum Coupland und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diabetes and Obesity, Helmholtz Munich, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany. Hauptthemen laut MEDLINE: Lysosomes, Glucagon-Like Peptide 1, Estrone, Estradiol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Deutsche Forschungsgemeinschaft, Helmholtz Association.
Abstract (Originalsprache)
OBJECTIVE: Recent modifications to glucagon-like peptide 1 (GLP-1), known for its insulinotropic and satiety-inducing effects, have focused on conjugating small molecules to enable selective delivery into GLP-1R+ tissues to achieve targeted synergy and improved metabolic outcomes. Despite continued advancements in GLP-1/small molecule conjugate strategies, the intracellular mechanisms facilitating concurrent GLP-1R signaling and small molecule cargo release remain poorly understood. METHODS: We evaluate an estradiol (E2)-conjugated GLP-1 (GLP-1-CEX/E2) for relative differences in GLP-1R signaling and trafficking, and elucidate endolysosomal dynamics that lead to estrogenic activity using various live-cell, reporter, imaging, and mass-spectrometry techniques. RESULTS: We find GLP-1-CEX/E2 does not differentially activate or traffic the GLP-1R relative to its unconjugated GLP-1 backbone (GLP-1-CEX), but uniquely internalizes the E2 moiety and stimulates estrogenic signaling. Endolysosomal pH-dependent proteolytic activity likely mediates E2 moiety liberation, as evidenced by clear amplification in estrogenic activity following co-administration with lysosomal VATPase activator EN6. The hypothesized liberated metabolite from GLP-1-CEX/E2, E2-3-ether, exhibits partial estrogenic efficacy through ERα, and is predisposed toward estrone-3-sulfate conversion. Finally, we identify relative increases in intracellular E2, estrone, and estrone-3-sulfate following GLP-1-CEX/E2 incubation in GLP-1R+ cells, demonstrating proof-of-principle for desired cargo release. CONCLUSION: Together, our data suggest that GLP-1-CEX/E2 depends on GLP-1R trafficking and lysosome acidification for estrogenic efficacy, with a likely conversion of the liberated E2-3-ether metabolite into estrone-3-sulfate, resulting in a residual downstream flux into active estradiol. Our current findings aim to improve the understanding of small molecule targeting and the efficacy behind GLP-1/small molecule conjugates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Diabetes and Obesity, Helmholtz Munich, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.
- Analytical Pathology Unit, Helmholtz Munich, Neuherberg, Germany.
- Institute for Diabetes and Obesity, Helmholtz Munich, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Department of Pharmacology, Experimental Therapy & Toxicology, Institute of Expe…
- Institute for Diabetes and Obesity, Helmholtz Munich, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Department of Physiology, Faculty of Medical Sciences in Katowice, Medical Unive…
- Institute for Diabetes and Obesity, Helmholtz Munich, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute of Physiotherapy and Health Sciences, Academy of Physical Education, K…
- Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA; Dexatide LLC, Plainfield, IN, USA.
Förderung
- European Research Council
- Deutsche Forschungsgemeinschaft
- Helmholtz Association
- European Commission
- Deutsches Zentrum für Diabetesforschung
Zitieren
APA
Coupland, C., Sun, N., Khalil, A., Karaoglu, Ö. E., Liskiewicz, A., Liskiewicz, D., Grandl, G., Akindehin, S., Maity, G., Yang, B., Finan, B., Knerr, P., Douros, J. D., Walch, A., DiMarchi, R., Tschöp, M. H., Müller, T. D., & Novikoff, A. (2025). Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism. Molecular Metabolism. https://doi.org/10.1016/j.molmet.2025.102136
Vancouver
Coupland C, Sun N, Khalil A, Karaoglu ÖE, Liskiewicz A, Liskiewicz D, et al. Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism. Molecular Metabolism. 2025. doi:10.1016/j.molmet.2025.102136
BibTeX
@article{Coupland2025,
author = {Coupland, Callum and Sun, Na and Khalil, Ahmed and Karaoglu, Özüm Ezgi and Liskiewicz, Arkadiusz and Liskiewicz, Daniela and Grandl, Gerald and Akindehin, Seun and Maity, Gandhari and Yang, Bin and Finan, Brian and Knerr, Patrick and Douros, Jonathan D and Walch, Axel and DiMarchi, Richard and Tschöp, Matthias H and Müller, Timo D and Novikoff, Aaron},
title = {Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism},
journal = {Molecular Metabolism},
year = {2025},
doi = {10.1016/j.molmet.2025.102136}
}
EUVIMED